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Summary
Synaptic plasticity, the cellular correlate for learning
and memory, involves signaling cascades in the den-
dritic spine. Extensive studies have shown that long-
term potentiation (LTP) of the excitatory postsynaptic
current (EPSC) through glutamate receptors is in-
duced by activation of N-methyl-D-asparate receptor
(NMDA-R)—the coincidence detector—and Ca2+/cal-
modulin-dependent protein kinase II (CaMKII). Here
we report that the same signaling pathway in the
postsynaptic CA1 pyramidal neuron also causes LTP
of the slow inhibitory postsynaptic current (sIPSC)
mediated by metabotropic GABAB receptors (GABAB-
Rs) and G protein-activated inwardly rectifying K+
(GIRK) channels, both residing in dendritic spines as
well as shafts. Indicative of intriguing differences in
the regulatory mechanisms for excitatory and inhibi-
tory synaptic plasticity, LTP of sIPSC but not EPSC
was abolished in mice lacking Nova-2, a neuronal-
specific RNA binding protein that is an autoimmune
target in paraneoplastic opsoclonus myoclonus
ataxia (POMA) patients with latent cancer, reduced in-
hibitory control of movements, and dementia.
Introduction
Signaling between neurons involves not only ionotropic
receptors, ligand-gated ion channels that generate fast
synaptic potentials, but also metabotropic receptors—
G protein-coupled receptors with prolonged effects
(Hille, 1992). The spines, small protrusions from den-
drites, harbor the great majority of excitatory synapses
and both types of glutamate receptors (Harris, 1999;
Sheng and Kim, 2002), whereas dendritic shafts provide
the setting for most inhibitory synapses involving
γ-aminobutyric acid (GABA), the major inhibitory trans-
mitter in the mammalian brain (Somogyi et al., 1998).
Intrigued by the finding that metabotropic GABAB re-
ceptors (GABAB-Rs) and G protein-activated inwardly
rectifying K+ (GIRK) channels reside on not only den-*Correspondence: gkw@itsa.ucsf.edu
5 These authors contributed equally to this work.dritic shafts but also the spines (Drake et al., 1997;
Kulik et al., 2003), we wondered whether the slow syn-
aptic inhibition mediated by GABAB-Rs and GIRK chan-
nels (Lüscher et al., 1997; Marshall et al., 1999) is af-
fected by the machinery in the spine for inducing
synaptic plasticity of the glutamate-receptor-mediated
excitatory postsynaptic current (EPSC) (Harris, 1999;
Malinow, 2003; Nicoll, 2003; Sheng and Kim, 2002).
Intensive studies over decades have identified
N-methyl-D-asparate receptor (NMDA-R) as the coinci-
dence detector that allows the postsynaptic neuron to
respond to synchronous excitatory inputs with long-
lasting changes of synaptic excitation mediated by
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
receptors (AMPA-Rs) (Bliss and Collingridge, 1993).
Optimal NMDA-R activation requires glutamate binding
concurrent with postsynaptic depolarization to relieve
channel block by external Mg2+ ions, so as to allow
Ca2+ and other cations to go through, thereby activa-
ting downstream second messengers such as Ca2+/cal-
modulin-dependent protein kinase II (CaMKII) and alter-
ing synaptic efficacy (Daw et al., 1993). It is an open
question whether the signaling cascade mobilized by
activation of NMDA-Rs also has long-lasting effects on
the slow inhibitory postsynaptic current (sIPSC) medi-
ated by GABAB-Rs and GIRK channels that localize in
dendritic spines of glutamatergic neurons, such as CA1
pyramidal neurons, and could be activated via “spill-
over” of GABA released from inhibitory nerve terminals.
In this study, we found that coincidence detection of
synaptic release of glutamate and CA1 pyramidal-neu-
ron depolarization caused long-term potentiation (LTP)
of sIPSC, a process dependent on postsynaptic NMDA-R
activation, Ca2+ increase, and CaMKII activity. To fur-
ther explore the functional requirement for this novel
form of synaptic plasticity, we examined the role of the
RNA binding protein Nova-2, an autoimmune target
likely important for cognitive functions (Albert and Dar-
nell, 2004; Yang et al., 1998).
Paraneoplastic opsoclonus myoclonus ataxia (POMA)
patients, often with latent breast cancer, fallopian can-
cer, or small cell lung cancer, display ataxic movements
and cognitive loss, probably due to the autoimmune
responses developed against neuronal-specific anti-
gens expressed by their cancer cells (Buckanovich et
al., 1993; Hormigo et al., 1994; Luque et al., 1991; Pran-
zatelli, 1992). The proteins recognized by their autoim-
mune antibodies, Nova-1 and Nova-2, are RNA binding
proteins that control alternative splicing of multiple
gene products for the establishment and function of the
central neuronal circuitry (Jensen et al., 2000; Ule et al.,
2005). Interestingly, many of the targets of Nova-1 and
Nova-2 contribute to inhibitory synaptic transmission
and/or synaptic plasticity. Whereas Nova-1 acts primar-
ily in the spinal cord, Nova-2 is expressed mostly in the
brain and associates with the RNAs coding for GABAB-
Rs and GIRK channels (Jensen et al., 2000; Ule et al.,
2003; Yang et al., 1998), essential molecular mediators
of sIPSC.
Interestingly, while the Nova-2 null mice exhibited
Cell
106basal sIPSC comparable to that in control sibling mice,
they failed to show LTP of sIPSC, indicating that one
of the physiological functions of Nova-2 is to enable
activity-dependent modulation of the strength of slow
synaptic inhibition. Because the Nova-2 null mice still
exhibited LTP of EPSC, Nova-2 appears to be specific-
ally involved in the NMDA-R-mediated synaptic plastic-
ity of slow synaptic inhibition.
Results
GIRK2 Also Resides in the Dendritic Spines
of Hippocampal Neurons
GABA causes slow synaptic inhibition by stimulating
GABAB-Rs so as to release Gβγ subunits for GIRK-chan-
nel activation (Lüscher et al., 1997). Whereas GABAB-Rs
are obligate dimers of the R1 and R2 subunits (Marshall
et al., 1999), GIRK channels in most central neurons are
heterotetramers containing GIRK1 and GIRK2 subunits
(Liao et al., 1996; Wickman et al., 2000; Yamada et al.,
1998). We therefore began our study by testing whether
GIRK2, like GABAB-Rs and GIRK1 (Drake et al., 1997;
Kulik et al., 2003), also resides in spines. Indeed, in cul-
tured rat hippocampal neurons expressing the en-
hanced green fluorescence protein (EGFP) to highlight
the spines, strong GIRK2 immunofluorescence was
found in the spines (Figure 1A), which house excitatory
synapses and harbor the signaling cascade for the LTP
of EPSC (Figure 1B) (Harris, 1999; Lisman et al., 2002;
Sheng and Kim, 2002).
The sIPSC Mediated by GABAB-Rs and GIRK
Channels in CA1 Pyramidal Neurons
To ask whether activation of NMDA-R in the spines
causes long-lasting changes of sIPSC, we used rat hip-
pocampal organotypic slice culture, a well-established
preparation for studying LTP of the EPSC (Hayashi et
al., 2000; Stein et al., 2003), and used the pairing proto-
col for optimal NMDA-R activation (Hayashi et al., 2000;
Kauer et al., 1988). Because CA1 pyramidal neurons
and their distal apical dendrites, which possess many
GIRK1-containing spines (Drake et al., 1997), tend to
receive inhibitory synaptic inputs from interneurons
that straddle the border of stratum radiatum (s.r.) and
stratum lacunosum-moleculare (s.l.m.) (Vida et al.,
1998), we placed the stimulation electrode 300–500 m
from stratum pyramidale (s.p.)—likely within s.l.m. By
giving test stimuli at a low frequency to sample the
sIPSC before and after the pairing, we asked whether
NMDA-R activation via the pairing protocol could alter
the sIPSC.
We recorded sIPSC from CA1 pyramidal neurons with
whole-cell patch-clamp in the presence of antagonists
for AMPA-Rs (5 M NBQX) and GABAA-Rs (100 M pic-
rotoxin) and used relatively large nerve stimulation to
elicit detectable sIPSC with a single stimulus. With the
resultant activation of a large number of glutamatergic
nerve fibers, the basal NMDA-R activation (Collingridge
et al., 1988) yielded a detectable inward current (NMDA-R
EPSC) while neurons were held at −60 mV (Figure 1C),
though optimal NMDA-R activation still required depo-
larization to between −20 mV and 0 mV (see Figure S1
in the Supplemental Data available with this article on-
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pine). The NMDA-R EPSC (peak latency, 31 ± 9 msec)
as followed with a slow outward current (peak latency,
20 ± 81 msec)—the sIPSC, which was blocked by two
tructurally unrelated GIRK-channel blockers, SCH23390
10 M, n = 6) (Kuzhikandathil and Oxford, 2002) (Figure
C) and tertiapin (100 nM, n = 4) (Bichet et al., 2004)
Figure 1D), and the GABAB-R antagonist SCH50911 (25
M, n = 7) (Bolser et al., 1995) (Figure 1E). There was
elatively little correlation between the amplitudes of
MDA-R EPSC and sIPSC (linear correlation coefficient
2 = 0.5), both of which remained stable when sampled
t 0.33 Hz (sIPSC, 93% ± 10% at w20 min, n = 9, p =
.3; NMDA-R EPSC, 110% ± 4% at w20 min, n = 9, p =
.6) (Figure 2A).
he Pairing Protocol Causes Long-Lasting
otentiation of the sIPSC
airing 3 Hz stimulation with depolarization (between
5 mV and 0 mV) for w2.5 min caused potentiation of
IPSC recorded at −60 mV with 0.33 Hz stimulation.
his sIPSC potentiation was robust and long lasting;
he sIPSC amplitude increased by w4-fold (415% ±
0% at w20 min after pairing, n = 12, p < 0.001), and
he potentiation persisted for w30 min—throughout the
uration of the experiment (Figure 2B)—without any
hanges of the input resistance or the series resistance
Figure 2C) or any significant pairing-induced changes
f the NMDA-R EPSC peak amplitude (136% ± 50% at
20 min after pairing, n = 12, p = 0.2) (Figure 2B) or
ecay time (measured in the presence of SCH50911,
BQX, and picrotoxin to isolate the NMDA-R EPSC;
7 ± 17 msec before pairing, n = 7; 90 ± 10 msec after
airing, n = 10, p = 0.7) (Figure 2D). Moreover, by meas-
ring the area of sIPSC instead of the peak amplitude,
e still observed a persistent and robust pairing-in-
uced potentiation (normalized area, 2.9 ± 0.5 at w20
in after pairing, n = 12, p < 0.05) (Figure 2E). There
as also no clear correlation between the extent of the
IPSC potentiation and the baseline amplitude of sIPSC
linear correlation R2 = 0.4) (Figure 2F) or NMDA-R
PSC (R2 = 0.1) (Figure 2G). Finally, whereas the poten-
iated sIPSC after pairing was sensitive to the GABAB-R
ntagonist SCH50911 (n = 4; Figure 3A) and the GIRK-
hannel blocker SCH23390 (n = 3; Figure 3B), the
ABAB-R activity was not required during pairing for
he sIPSC potentiation (257% ± 35% at w30 min after
airing, n = 8, p < 0.005; Figure 3C). Thus, pairing syn-
ptic glutamate release with CA1 pyramidal-neuron de-
olarization resulted in LTP of sIPSC.
We then asked whether the pairing protocol could
lso cause potentiation of sIPSC in CA1 pyramidal neu-
ons of acute hippocampal slices from 25- to 30-day-
ld rats. Because interneurons in the distal apical den-
ritic field of CA1 pyramidal neurons have a high target
reference for not only dendritic shafts but also spines
Vida et al., 1998) and the spines in s.l.m. are particu-
arly rich in GIRK1 immunoreactivity (Drake et al., 1997),
e selectively delivered stimuli to the perforant path at
.l.m. The baseline sIPSC sampled with 0.33 Hz stimu-
ation exhibited modest rundown; the sIPSC amplitude
20 min after initiation of whole-cell patch-clamp re-
ording was 80% ± 27% of the starting value (n = 13,
= 0.02) (Figure 3D). Nonetheless, the pairing protocol
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107Figure 1. Slow Synaptic Inhibition Mediated by GABAB-Rs and GIRK Channels
In this and all other figures, error bars indicate the standard errors of the mean; no error bars are shown when the standard errors are smaller
than the symbol used.
(A) Prominent GIRK2 immunofluorescence (red) in dendritic spines of EGFP-expressing neurons (green). Scale bar: 10 m.
(B) Signaling cascades in the spine for inducing LTP of EPSC. Glutamate concurrent with depolarization relieving the Mg2+ blockade causes
optimal NMDA-R activation, Ca2+ entry, and CaMKII activation.
(C) GIRK-channel blocker SCH23390 reduced the biphasic response (black) to the NMDA-R EPSC (blue) that is sensitive to APV (red) (n = 6).
The time course of sIPSC reduction is also shown.
(D) Another GIRK-channel blocker, tertiapin, also eliminated the sIPSC (n = 4).
(E) The sIPSC is sensitive to the GABAB-R antagonist SCH50911 (n = 7). The overlay of the last two panels is shown at different scale to
highlight the sIPSC.induced persistent potentiation of sIPSC (142% ± 13%
at w20 min after pairing, n = 14, p < 0.01) (Figure 3E).
Perhaps because of the relatively large stimulation
strength necessary for a single stimulus to elicit detect-
able sIPSCs in the acute slice, the pairing protocol
caused some potentiation of NMDA-R EPSC, similar towhat has been reported previously (Aniksztejn and
Ben-Ari, 1995; Bashir et al., 1991; Watt et al., 2004).
Thus, pairing postsynaptic depolarization with perfor-
ant-path stimulation was effective in inducing synaptic
plasticity in the acute slice. Moreover, without concur-
rent postsynaptic depolarization, the 3 Hz stimulation
Cell
108Figure 2. Pairing-Induced LTP of sIPSC in Hippocampal CA1 Pyramidal Neurons
(A) Hippocampal slice culture with fairly stable baseline of sIPSC (filled circles, n = 9, p = 0.3) and NMDAR-EPSC (open circles, n = 9, p = 0.6)
sampled at 0.33 Hz. Example traces (average of w40–60 episodes) are shown above plots of peak amplitudes in this and subsequent figures.
(B) Pairing 3 Hz stimulation with depolarization (−5 to 0 mV) for w2.5 min potentiated the sIPSC (filled circles, n = 12, p < 0.001) but not
NMDA-R EPSC (open circles, n = 12, p = 0.2).
(C) The series resistance Rs (top) and the input resistance Rin (bottom) remained constant after pairing (n = 12).
(D) The NMDA-R EPSC decay time constant (n = 7), measured in the presence of SCH50911, NBQX, and picrotoxin, was not altered after
pairing (n = 10, p = 0.7) (bottom). Sample traces (black) are compared with idealized traces generated with the average decay time constant
(red) (top).
(E) Pairing-induced LTP of the sIPSC as assessed by integrating the sIPSC amplitude over time (n = 12, p < 0.05).
(F) No correlation between the amplitude and the extent of sIPSC potentiation (linear correlation index R2 = 0.4). The average is shown in red
in this and the subsequent panel.
(G) No correlation between the extent of sIPSC potentiation and the NMDA-R EPSC amplitude (R2 = 0.1).
LTP of Slow Synaptic Inhibition Requires Nova-2
109Figure 3. Pairing-Induced sIPSC Potentiation in Slice Cultures and Acute Slices
(A) The potentiated sIPSC in slice culture was sensitive to the GABAB-R antagonist SCH50911 (n = 4).
(B) The potentiated sIPSC was sensitive to the GIRK-channel blocker SCH23390 (n = 3).
(C) Blocking the GABAB-Rs with SCH50911 during pairing did not prevent the induction of sIPSC LTP in slice culture (n = 8, p < 0.005).
(D) Acute hippocampal slice exhibited modest rundown of the sIPSC (n = 13, p = 0.02) elicited with perforant-path stimulation.
(E) Pairing-induced potentiation of sIPSC elicited with perforant-path stimulation (n = 14, p < 0.01) in acute slices.
(F) Perforant-path stimulation at 3 Hz without concurrent depolarization caused no potentiation of sIPSC in acute slices (n = 8, p < 0.01).failed to potentiate the sIPSC (65% ± 14% at w20 min
after pairing, n = 8, p < 0.01; Figure 3F), suggesting that
pairing-induced NMDA-R activation is necessary for
sIPSC LTP.
Potentiation of the sIPSC Requires NMDA-R
Activation in the Postsynaptic CA1
Pyramidal Neuron
To test whether NMDA-R activity is necessary for pair-
ing-induced sIPSC potentiation in slice culture, we firstapplied the NMDA-R antagonist APV (100 M) and
found no pairing-induced LTP of the sIPSC (102% ±
20% at w20 min after pairing, n = 7, p = 0.1) (Figure 4A).
However, not only was the inward current very small in
the presence of antagonists for both NMDA-R and
AMPA-R, the sIPSC amplitude was greatly reduced,
likely due to inefficient synaptic excitation of the inhibi-
tory interneurons to generate disynaptic sIPSC. We
therefore conducted two additional controls. First, we
stimulated presynaptic fibers at 3 Hz without depolariz-
Cell
110Figure 4. Postsynaptic Ca2+ and NMDA-R Activity Are Necessary for Inducing LTP of sIPSC
(A) Treatment of slice culture with APV as well as NBQX reduced both EPSC and sIPSC amplitudes and eliminated LTP of sIPSC (n = 7, p = 0.1).
(B) Three hertz stimulation without concurrent postsynaptic depolarization failed to induce sustained potentiation of sIPSC (n = 6, p = 0.1).
(C) Treatment with the NMDA-R antagonist APV but not the AMPA-R antagonist NBQX eliminated LTP of sIPSC (n = 6, p = 0.3) while preserving
its size.
(D) Chelating postsynaptic Ca2+ with 10 mM BAPTA in the pipette solution abolished LTP of sIPSC (n = 6, p = 0.6).ing the postsynaptic pyramidal neuron and found that,
analogous to our observations with the acute slice (Fig-
ure 3F), there was no persistent potentiation of the
sIPSC (123% ± 26% at w20 min after pairing, n = 6, p =
0.1) (Figure 4B). Second, when we treated the cultured
slices only with antagonists of the GABAA-Rs and
NMDA-Rs, there was no pairing-induced potentiation of
the biphasic response composed of AMPA-R-mediated
EPSC (AMPA-R EPSC) and the sIPSC (90% ± 12%, n =
6, p = 0.3) (Figure 4C). These experiments confirm that
NMDA-R activation via the pairing protocol is required
for LTP of the sIPSC.
Induction of the sIPSC LTP Is Dependent
on Postsynaptic Ca2+ Increase
To ask whether sIPSC potentiation is due to Ca2+ influx
through NMDA-Rs, we tested the effect of chelating in-
ternal Ca2+ and blocking Ca2+ channels and whether
LTP of sIPSC is induced locally near the activated syn-
apses on dendrites. Whereas the pairing protocol still
caused LTP of sIPSC when the intracellular Ca2+ level
was moderately buffered by 1.1 mM EGTA, no potentia-
tion of sIPSC could be induced with 10 mM BAPTA in
the patch pipette solution (87% ± 19% at w20 min after
pairing, n = 6, p = 0.6) (Figure 4D). A rise in postsynaptic
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ince Oregon green BAPTA 488-1 or lucifer yellow—flu-
rescent markers of sizes comparable to BAPTA—
ould diffuse from the pipette solution to distal apical
endrites within 5–10 min after whole-cell patch-clamp
as established (Figure S2). Blocking voltage-gated
a2+ channels with nifedipine (100 M), however, did
ot eliminate pairing-induced LTP of sIPSC (295% ±
3% at w20 min after pairing, n = 7, p < 0.01; Figure
3). Moreover, pairing depolarization with stimulation of
erve fibers near proximal dendrites (pathway 2) did not
ause potentiation of sIPSC elicited by nerve stimula-
ion near distal dendrites (pathway 1) of CA1 pyramidal
eurons (107% ± 26% atw20 min after pairing for path-
ay 2, n = 8, p = 0.2; Figure S4). Taken together, these
indings suggest that Ca2+ influx through NMDA-Rs is
ssential for the induction of LTP of sIPSC.
Even though pairing-induced potentiation of the
IPSC requires postsynaptic NMDA-R activation and
a2+ rise, a priori, it remains possible that this potentia-
ion could result from increased GABA release, perhaps
y retrograde signaling via endocannabinoids (Cheva-
eyre and Castillo, 2003; Piomelli, 2003; Wilson and Ni-
oll, 2001). However, the CB1 cannabinoid-receptor an-
agonist AM251 (2 M) did not affect pairing-induced
LTP of Slow Synaptic Inhibition Requires Nova-2
111LTP of sIPSC (370% ± 33% at w20 min after pairing,
n = 5, p < 0.001). Moreover, the pairing protocol did not
alter GABA release to an extent that affected the
paired-pulse ratio of the GABAA-R mediated fIPSC (be-
fore pairing, 0.74 ± 0.04; 10 min after pairing, 0.74 ±
0.05, p = 0.9; 20 min after pairing, 0.70 ± 0.04, p = 0.5;
n = 5); the paired-pulse ratio’s sensitivity to transmitter
release was verified by varying Ca2+ concentrations in
control experiments. Thus, the pairing-induced LTP of
sIPSC could not be attributed to CB1 receptor-medi-
ated endocannabinoid retrograde signaling or increased
GABA release.
Activation of CaMKII Is Necessary and Sufficient
for Inducing sIPSC Potentiation
CaMKII activity is necessary for sIPSC potentiation be-
cause treatment of the slice culture with 10 M KN-
93, a selective inhibitor of CaMKII, eliminated pairing-
induced LTP of sIPSC (90% ± 15% at w20 min after
pairing, n = 11, p = 0.6) (Figure 5A). To ask whether
postsynaptic CaMKII activity is also sufficient for sIPSC
potentiation, we utilized the Sindbis virus to introduce
into CA1 pyramidal neurons the constitutively active
enzyme fused with EGFP, CaMKII(1–290)-EGFP; the
great majority of the infected neurons were gluta-
matergic pyramidal neurons. For internal control, we
simultaneously recorded from an uninfected neuron
and a nearby neuron expressing CaMKII(1–290)-EGFP
(Figure 5B) and compared their sIPSCs that were elic-
ited with the same condition for synaptic stimulation.
The constitutively active CaMKII potentiated the
sIPSC (neurons expressing CaMKII(1–290)-EGFP, 6.1 ±
0.5 pA; neighboring control neurons, 3.0 ± 1.0 pA; n =
16, p < 0.0005) but not the NMDA-R EPSC (neurons
expressing CaMKII(1–290)-EGFP, 46.0 ± 10.7 pA; neigh-
boring control neurons, 47.5 ± 12.5 pA; n = 17, p = 0.4)
(Figure 5D). In control experiments, neurons expressing
EGFP and their neighboring uninfected neurons yielded
similar sIPSC (neurons expressing EGFP, 2.9 ± 0.7 pA;
neighboring control neurons, 3.1 ± 0.9 pA; n = 18, p =
0.8) and NMDA-R EPSC (neurons expressing EGFP,
38.8 ± 5.1 pA; neighboring control neurons, 40.9 ± 6.0
pA; n = 24, p = 0.4) (Figure 5C). Not only was constitu-
tively active CaMKII sufficient for potentiating the
sIPSC, it occluded pairing-induced LTP of sIPSC; neu-
rons expressing CaMKII(1–290)-EGFP showed no fur-
ther potentiation of sIPSC after pairing (113% ± 54%,
n = 7, p = 0.1), while control neurons expressing EGFP
still exhibited pairing-induced LTP of sIPSC (287% ±
43%, n = 4, p < 0.01) (Figure 5E). These experiments
demonstrate that sIPSC was potentiated by the activa-
tion of CaMKII in the postsynaptic CA1 pyramidal
neurons.
The Nova-2 RNA Binding Protein Is Essential
for Pairing-Induced sIPSC Potentiation
Having established that the sIPSC mediated by
GABAB-Rs and GIRK channels can be potentiated by
activation of NMDA-Rs and CaMKII in CA1 pyramidal
neurons, we wondered whether this synaptic plasticity
of slow inhibition might be subjected to concerted
modulation of relevant synaptic proteins. One candi-
date for coordinating such modulation is Nova-2 be-cause it regulates a network of synaptic proteins and
one-third of its targets are molecules involved in inhibi-
tory synaptic transmission, including GABAB-Rs and
GIRK channels (Ule et al., 2003, 2005).
To characterize synaptic transmission and plasticity
in the Nova-2 null mice (Ule et al., 2003) (Figure S5),
which lived for 2–3 weeks after birth, we first measured
the resting membrane potential of CA1 pyramidal neu-
rons in hippocampal slice culture and found no differ-
ence between Nova-2 null mice (−60.6 ± 3.5 mV, n = 8)
and their heterozygous siblings (–59.4 ± 3.1 mV, n = 5,
p = 0.5). Next, we examined the miniature EPSCs and
found no effect of the null mutation on the amplitude
(Nova-2−/−, 3.5 ± 0.3 pA; Nova-2+/−, 3.9 ± 0.6 pA; n = 7,
p = 0.5) or frequency (Nova-2−/−, 0.5 ± 0.2 Hz; Nova-2+/−,
0.4 ± 0.2 Hz; n = 7, p = 0.7) of these unitary responses
(Figure 6A). We also found similar ratios of AMPA-R
EPSC measured at −60 mV and NMDA-R EPSC at +40
mV (Nova-2−/−, 2.3 ± 0.9, n = 8; Nova-2+/−, 2.5 ± 0.8, n =
7; p = 0.9) (Figure 6B). Moreover, when we recorded the
NMDA-R-mediated EPSC at different membrane poten-
tials in the presence of the AMPA-R antagonist NBQX,
we found comparable voltage dependence of the
NMDA-R EPSC in Nova-2 null mutants and their hetero-
zygous sib controls (Figure 6C). Finally, the pairing pro-
tocol elicited LTP of EPSC in both heterozygous control
mice (pairing pathway, 171% ± 14%, n = 10, p < 0.01;
control pathway, 99% ± 8%, n = 5, p = 0.8) and Nova-2
null mice (pairing pathway, 177% ± 14%, n = 9, p < 0.01;
control pathway, 99% ± 13%, n = 4, p = 0.9) (Figure 6D).
These experiments thus revealed no significant differ-
ences between Nova-2 null mice and control mice in
excitatory synaptic transmission.
To test whether Nova-2 function is important for in-
hibitory synaptic transmission, we compared the null
mutants with their heterozygous siblings and found no
difference in the miniature fIPSC amplitude (Nova-2−/−,
5.3 ± 0.4 pA; Nova-2+/−, 5.2 ± 0.7 pA; n = 5, p = 0.8) or
frequency (Nova-2−/−, 1.4 ± 0.3 Hz; Nova-2+/−, 1.6 ± 0.4
Hz; n = 5, p = 0.4) (Figure 7A). Moreover, we observed
similar ratios of the sIPSC and fIPSC amplitudes, over
a wide range of stimulation strength, in the null mutants
and their heterozygous siblings (Nova-2−/−, 0.07 ± 0.02;
Nova-2+/−, 0.08 ± 0.02; n = 8, p = 0.2) (Figure 7B). Finally,
in cultured slices treated with NBQX and picrotoxin to
block AMPA-Rs and GABAA-Rs, the ratio of the sIPSC
and NMDA-R EPSC amplitudes was also normal in the
null mutants (Nova-2−/−, 0.5 ± 0.1; Nova-2+/−, 0.4 ± 0.1;
n = 15, p = 0.4) (Figure 7C).
Interestingly, whereas their heterozygous siblings
yielded normal pairing-induced potentiation of sIPSC
(338% ± 39% at w20 min after pairing, n = 6, p < 0.01),
the Nova-2 null mutants exhibited no pairing-induced
LTP of the sIPSC (130% ± 38% at w20 min after pair-
ing, n = 8, p = 0.5) (Figure 7D). Since the basal synaptic
transmission appeared normal for excitation (Figures
6A and 6B) and inhibition (Figures 7A and 7B) and the
capacity of inducing LTP of the EPSC remained in the
Nova-2 null mutant (Figure 6D), it appears that the ma-
chinery essential for potentiating the slow synaptic in-
hibition mediated by the GABAB-Rs and GIRK channels
is specifically impaired in Nova-2 null mice.
Cell
112Figure 5. CaMKII Activity Is Necessary and Sufficient for Inducing LTP of sIPSC
(A) The CaMKII inhibitor KN-93 prevented pairing-induced sIPSC potentiation (n = 11, p = 0.6).
(B) Images of CA1 neurons expressing CaMKII(1–290)-EGFP (left) and pairwise recording from one infected neuron and a nearby uninfected
neuron (dotted outline) visualized with transmitted light (upper right) and epifluorescence (lower right). Scale bars: 25 m.
(C) Pairwise comparison between control infected neurons expressing EGFP and nearby uninfected neurons revealed no difference in sIPSC
(n = 18, p = 0.8) or NMDAR-EPSC (n = 24, p = 0.4).
(D) Expression of constitutively active CaMKII(1–290)-EGFP potentiated sIPSC (n = 16, p < 0.0005) but not NMDA-R EPSC (n = 17, p = 0.4).
(E) No further potentiation of sIPSC in neurons expressing CaMKII(1–290)-EGFP (n = 7, p = 0.1), in contrast to control neurons expressing
EGFP (n = 4, p < 0.01).Discussion
Neurotransmitters not only induce rapid potential
changes in the millisecond timescale via ionotropic re-
ceptors, they activate G protein-coupled metabotropic
receptors to influence neuronal activity for seconds if
not minutes (Hille, 2001). Moreover, the metabotropic
receptors’ ability to respond to transmitters released
at a distance allows neurons to integrate and process
multiple synaptic inputs. Prompted by the unexpected
localization of both GABA -Rs and GIRK channels to
t
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t
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t
sBhe dendritic spines (Drake et al., 1997; Kulik et al.,
003)—where excitatory synapses reside and LTP of
PSC could be induced—our study uncovered a new
orm of synaptic plasticity, LTP of sIPSC mediated by
ABAB-Rs and GIRK channels (Figure 2), due to activa-
ion of NMDA-Rs as the coincidence detector (Figures
A–4C).
In addition to identifying the mechanism common to
TP of EPSC and LTP of sIPSC, we came upon regula-
ory machinery specific for the synaptic plasticity of
low inhibition. Like LTP of EPSC (Malenka et al., 1988,
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113Figure 6. Nova-2 Null Mice Exhibit Excitatory Synaptic Responses and LTP of EPSC Similar to those of Their Heterozygous Siblings
(A) The miniature EPSC of Nova-2 null mice (−/−) exhibited amplitude (n = 7, p = 0.5) and frequency (n = 7, p = 0.7) (blue) similar to those of
heterozygous siblings (+/−) (black). The same color label is used in subsequent panels and figures.
(B) The ratio of AMPA-R EPSC and NMDA-R EPSC was comparable between Nova-2 null mice and heterozygous siblings (n = 8, p = 0.9).
(C) The voltage dependence of NMDA-R EPSC was comparable between Nova-2 null mice and heterozygous siblings (n = 6, p = 0.2).
(D) Similar pairing-induced LTP of EPSC in Nova-2 null mice and their heterozygous siblings.
Cell
114Figure 7. Nova-2 Null Mice with Normal Basal Inhibitory Synaptic Responses, as Compared with Heterozygous Controls, Fail to Show Pairing-
Induced LTP of sIPSC
(A) The miniature fIPSC of Nova-2 null mice (−/−) showed normal amplitude (n = 5, p = 0.8) and frequency (n = 5, p = 0.4).
(B) The ratio of sIPSC and fIPSC in Nova-2 null mice (n = 8) was similar to that in control mice (+/−) (n = 8, p = 0.2).
(C) The ratio of sIPSC and NMDA-R EPSC in Nova-2 null mutants (n = 15) was comparable to that in control mice (n = 15, p = 0.4).
(D) Nova-2 null mice exhibited no pairing-induced sIPSC potentiation (n = 8, p = 0.5), while their heterozygous siblings showed pairing-
induced sIPSC LTP (n = 6, p < 0.01).1989; Malinow et al., 1989), LTP of sIPSC requires post-
synaptic Ca2+ rise (Figure 4D) and CaMKII activity (Fig-
ure 5A). Moreover, expression of constitutively active
CaMKII in CA1 pyramidal neurons was sufficient to po-
tentiate sIPSC (Figure 5D) and to occlude pairing-
induced LTP of sIPSC (Figure 5E). Remarkably, LTP of
sIPSC but not EPSC was absent in the Nova-2 null mice
(Figures 6 and 7), raising the intriguing possibility that
one of the physiological functions of the Nova-2 RNA
binding protein is to enable central neurons to adjust
their slow synaptic inhibition based on neuronal ac-
tivity.
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iong-Term Potentiation of Slow Synaptic Inhibition
ould Sharpen the Coincidence Detection
f Excitatory Synaptic Inputs
ne potential consequence of sIPSC potentiation is to
arrow the time window for the coincidence detection
f excitatory inputs; late-arriving synaptic inputs would
e rendered less effective because of the hyperpolar-
zation and increased membrane conductance accom-
anying the potentiated sIPSC. Importantly, in small
tructures like the dendritic spines, slow synaptic inhi-
ition mediated by K+ channel activation via GABAB-Rs
s likely to be more effective in dampening the excit-
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115atory inputs—in principle—than the fast synaptic inhibi-
tion, since Cl− influx through GABAA-Rs into small
structures could significantly increase the concentra-
tion and hence decrease the driving force for Cl− (Qian
and Sejnowski, 1990). Thus, the localization of both
GABAB-Rs and GIRK channels in dendritic spines (Fig-
ure 1A) (Drake et al., 1997; Kulik et al., 2003) not only
enables the same signaling pathway for synaptic plas-
ticity of excitatory synaptic potentials to induce long-
lasting changes of slow synaptic inhibition, potentiation
of slow inhibition due to GIRK channel activity also rep-
resents one highly effective way of harnessing excit-
atory synaptic inputs.
In addition to reducing excitation at dendritic spines,
slow synaptic inhibition may also induce failures of ac-
tion-potential propagation along axons, particularly at
axonal branch points (Debanne, 2004; Debanne et al.,
1997; Kopysova and Debanne, 1998). Thus, potentia-
tion of sIPSC could sharpen the coincidence detection
of synchronous excitatory synaptic inputs, a hallmark
for learning and memory, in a variety of ways—by re-
ducing the impact of late-arriving excitatory inputs
within the spines that receive the synaptic excitation
and by decreasing the likelihood that excitation by late-
arriving synaptic inputs will be productive in causing
transmitter release from the nerve terminals.
Long-term potentiation of slow synaptic inhibition
may also modulate rhythmic activities such as the theta
oscillation (4–7 Hz), which is important for learning and
memory (Hyman et al., 2003; O’Keefe, 1993; Sederberg
et al., 2003; Seidenbecher et al., 2003). Interneurons are
remarkably effective in synchronizing this oscillatory fir-
ing pattern of hippocampal pyramidal neurons (Cobb
et al., 1995). It is of interest to note that GABA-uptake
blocker causes a decrease in the oscillation frequency,
which can be reversed by blockade of GABAB-Rs
(Scanziani, 2000). If theta modulation indeed depends
on postsynaptic GABAB-Rs, LTP of sIPSC is likely to
slow theta oscillation and hence shift its phase, a cru-
cial temporal parameter in filtering out specific synaptic
activities for potentiation or depression (Hyman et al.,
2003).
Nova-2 Functions and Synaptic Plasticity
of Slow Inhibition
Nova proteins bind to known sequence motifs in the
RNA with high affinity to regulate alternative splicing
and may also associate with other RNA sequences in
exons (Dredge and Darnell, 2003; Dredge et al., 2005;
Jensen et al., 2000; Musunuru and Darnell, 2001; Ule et
al., 2003, 2005). As paraneoplastic neurologic disease
antigens, these RNA binding proteins are probably re-
sponsible for the reduced inhibitory control of move-
ments and dementia in POMA patients (Albert and Dar-
nell, 2004; Buckanovich et al., 1993; Hormigo et al.,
1994; Pranzatelli, 1992; Yang et al., 1998). Interestingly,
many RNAs that are Nova-2 targets code for proteins
that mediate synaptic inhibition, including GABAB-Rs
and GIRK channels (Ule et al., 2003, 2005). The ability
of hippocampal neurons from Nova-2 null mice to ex-
hibit LTP of EPSC (Figure 6) but not sIPSC (Figure 7)
strongly suggests that Nova-2 functions specifically in
the machinery that endows slow synaptic inhibitionwith the capacity to respond to NMDA-R activation with
long-lasting changes.
How might Nova-2 contribute to synaptic plasticity
of slow inhibition? Multiple variants for both GABAB-R
and GIRK channels exist due to alternative splicing
(Isomoto et al., 1998; Martin et al., 2001; Pfaff et al.,
1999; Wei et al., 1998) or alternative promoter usage
(Steiger et al., 2004) to diversify their function and their
traffic pattern (Charles et al., 2001; Ma et al., 2002; Mar-
tin et al., 2004). As an RNA binding protein known to
regulate splicing of molecules important for synaptic
transmission and plasticity (Ule et al., 2005), Nova-2
may function in CA1 pyramidal neurons to dictate ap-
propriate representations of the splice variants of
GABAB-Rs, GIRK channels, or other associated mole-
cules (Couve et al., 2001, 2004; Nehring et al., 2000;
Vernon et al., 2001; White et al., 2000), perhaps to en-
sure that these molecules in dendritic spines and other
synaptic sites are suitably equipped to respond to sig-
naling downstream of the coincidence detector, the
NMDA-R. While altered splicing patterns are evident
from analyses of different regions of the brain and spi-
nal cord from Nova-1 and Nova-2 null mice (Dredge and
Darnell, 2003; Jensen et al., 2000; Ule et al., 2005), fur-
ther studies will be necessary to uncover cell-type-spe-
cific functions of Nova proteins. In this regard, it is
worth noting that regulation of splicing of various K+
channels and Ca2+ channels in individual neurons, or
specific subsets of neurons, plays physiologically im-
portant roles in fine tuning excitability (Baranauskas et
al., 2003; Bell et al., 2004; Fettiplace and Fuchs, 1999).
Whereas Nova proteins are known to regulate alterna-
tive splicing, given the intriguing coupling between
RNA splicing and cytoplasmic RNA targeting and regu-
lation (Gu et al., 2002; Hachet and Ephrussi, 2004; Ka-
taoka et al., 2000; Palacios, 2002), a physiological role
of Nova-2 outside the nucleus—in neuronal soma or
processes—remains an interesting possibility for fu-
ture studies.
Experimental Procedures
Immunocytochemistry
Primary cultures of rat hippocampal neurons (Brewer et al., 1993)
were transfected with EGFP constructs, fixed with 4% paraformal-
dehyde/4% sucrose in phosphate-buffered saline at 4°C for 20 min,
and exposed to GIRK2 antibodies (Alomone, Jerusalem, Israel) for
immunofluorescence.
Hippocampal Organotypic Slice Culture and Electrophysiology
Rat hippocampal organotypic slice cultures (Hayashi et al., 2000)
in a recording chamber superfused with ACSF solution containing
(in mM) 119 NaCl, 2.5 KCl, 4 CaCl2, 4 MgCl2, 26.2 NaHCO3, 1
NaH2PO4, 11 glucose and equilibrated with 5% CO2/95% O2 were
used for whole-cell recordings at room temperature from CA1 py-
ramidal neurons with patch electrodes (3–5 M) filled with pipette
solution containing (in mM) 140 K-gluconate, 5 HEPES, 2 MgCl2,
1.1 EGTA, 2 MgATP, 3 Na3GTP. Recordings were amplified with Ax-
onpatch 1D, filtered at 1 kHz, and sampled using programs written
in Igor (Wavematrics, Lake Oswego, Oregon). To evoke synaptic
responses, a cluster electrode (FHC, Bowdoinham, Maine) was
placed 300–500 m from the stratum pyramidale layer in the CA1
region, and stimuli of w0.1 msec duration were delivered. Data
were analyzed using macros written in Igor and Microsoft Excel.
Sindbis viruses and the CaMKII(1–290)-EGFP construct were con-
structed as reported (Hayashi et al., 2000), and recordings were
made 24 to 36 hr after neurons were infected. Recordings from cell
Cell
116pairs were performed with neurons whose somata were within w20
m, one showing EGFP fluorescence and the other not. For record-
ing miniature fIPSC at −70 mV and miniature EPSC at −60 mV, the
patch pipette was filled with the internal solution containing (in mM)
115 cesium methanesulfonate, 20 CsCl, 10 HEPES, 2.5 MgCl2, 4
Na2ATP, 0.4 Na3GTP, 10 sodium phosphocreatine, 0.6 EGTA (pH
7.25). The external solution contained the sodium-channel blocker
TTX (2 M) and blockers for glutamate receptors (5 M NBQX and
100 M APV) (for recording miniature fIPSC) or GABAA-R (100 M
picrotoxin) (for recording miniature EPSC). All recording was done
at room temperature. The amplitudes of AMPA-R and NMDA-R
EPSC were measured with an average of a 10–15 msec window at
the peak (at −60 mV) and w200 msec (at +40 mV) from the onset
of the synaptic currents, respectively. Drugs used were NBQX, pic-
rotoxin, SCH23390, SCH50911, AM251, and APV (Tocris, Ellisville,
Missouri); tertiapin (Alomone); and KN-93 (Calbiochem, San Diego,
California). Data are expressed as means ± SEM, and statistical
differences were determined using Student’s t test and nonpara-
metric Mann-Whitney or Wilcoxon tests.
Acute Hippocampal Slice
Brains from 25- to 30-day-old Sprague-Dawley rats (Charles River,
Wilmington, Massachusetts) were removed and immersed in cold
buffer containing (in mM) 87 NaCl, 25 NaHCO3, 75 sucrose, 10 glu-
cose, 2.5 KCl, 1 NaH2PO4, 0.5 CaCl2, 7 MgCl2 and equilibrated with
95% O2/5% CO2. Hippocampal slices w400 m thick were pre-
pared with Leica VT1000s vibratome; transferred to a holding
chamber with the ACSF solution containing (in mM) 119 NaCl, 2.5
KCl, 2.5 CaCl2, 1.3 MgCl2, 26.2 NaHCO3, 1 NaH2PO4, 11 glucose
and bubbled with 95%O2/5% CO2 at 37°C for w1 hr; and then incu-
bated at room temperature for at least 30 min before recording.
Nova-2 Mice
Hippocampal organotypic slice cultures were prepared from het-
erozygous and homozygous sibling mice with the same procedure
as for rat slice culture. Two pairs of primers designed to target the
wild-type locus and the mutant locus, respectively, were used for
genotyping: (1) 5#-GGATCCTCTAGAGTCACACC-3# and 5#-GGGTG
ACATGGAAGAAAGGG-3# and (2) 5#-TTTCCGTCTCTGGTGTAGC-3#
and 5#-GTGCACACACACATGTCC-3#. A band size of 450 bp is ex-
pected for the wild-type locus, and a band size of 550 bp is ex-
pected for the mutant locus.
Supplemental Data
Supplemental Data include five figures and can be found with this
article online at http://www.cell.com/cgi/content/full/123/1/105/DC1/.
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